A Study of Multiple Immune and Disease Treatment Combinations in Participants With ER+HER2- Breast Cancer That Has Spread
Clinical trial NCT04132817 · COMPLETED
Trial details
- NCT number
- NCT04132817
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-22
- Primary completion
- 2022-08-15
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.